Search research articles
Contact Us
Filters
Showing results (51-60 of 58) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 58 results.
Die Pharmazie
|
October 31, 2006
Pharmaceutical development, quality control, stability and compatibility of a parenteral lyophilized formulation of the investigational polymer-conjugated platinum antineoplastic agent AP5346
S C Van der Schoot, B Nuijen, P Sood, et al.
Anti-Cancer Drugs
|
October 24, 2002
Stability and compatibility of the investigational polymer-conjugated platinum anticancer agent AP 5280 in infusion systems and its hemolytic potential
M Bouma, B Nuijen, D R Stewart, et al.
Journal of Veterinary Pharmacology and Therapeutics
|
December 1, 1991
Clinical pharmacokinetics of parenterally administered danofloxacin in cattle
C J Giles, R A Magonigle, W T Grimshaw, et al.
Circulation
|
January 1, 1978
Cryoablation of drug-resistant ventricular tachycardia in a patient with a variant of scleroderma
J J Gallagher, R W Anderson, J Kasell, et al.
The Journal of Foot Surgery
|
January 1, 1984
Solitary osteochondroma of the foot: an in-depth study with case reports
C O Fuselier, T Binning, D Kushner, et al.
Clinical Immunology and Immunopathology
|
February 1, 1990
Expression of autoantibodies to recombinant (U1) RNP-associated 70K antigen in systemic lupus erythematosus
E W St Clair, C C Query, R Bentley, et al.
Drug Development and Industrial Pharmacy
|
November 11, 2003
Pharmaceutical development of a parenteral lyophilized formulation of the investigational polymer-conjugated platinum anticancer agent AP 5280
M Bouma, B Nuijen, R Harms, et al.
Archives of Toxicology
|
February 18, 2024
Demonstrating the reliability of in vivo metabolomics based chemical grouping: towards best practice
Mark R Viant, E Amstalden, T Athersuch, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 58) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 58 results.
Die Pharmazie
|
October 31, 2006
Pharmaceutical development, quality control, stability and compatibility of a parenteral lyophilized formulation of the investigational polymer-conjugated platinum antineoplastic agent AP5346
S C Van der Schoot, B Nuijen, P Sood, et al.
Anti-Cancer Drugs
|
October 24, 2002
Stability and compatibility of the investigational polymer-conjugated platinum anticancer agent AP 5280 in infusion systems and its hemolytic potential
M Bouma, B Nuijen, D R Stewart, et al.
Journal of Veterinary Pharmacology and Therapeutics
|
December 1, 1991
Clinical pharmacokinetics of parenterally administered danofloxacin in cattle
C J Giles, R A Magonigle, W T Grimshaw, et al.
Circulation
|
January 1, 1978
Cryoablation of drug-resistant ventricular tachycardia in a patient with a variant of scleroderma
J J Gallagher, R W Anderson, J Kasell, et al.
The Journal of Foot Surgery
|
January 1, 1984
Solitary osteochondroma of the foot: an in-depth study with case reports
C O Fuselier, T Binning, D Kushner, et al.
Clinical Immunology and Immunopathology
|
February 1, 1990
Expression of autoantibodies to recombinant (U1) RNP-associated 70K antigen in systemic lupus erythematosus
E W St Clair, C C Query, R Bentley, et al.
Drug Development and Industrial Pharmacy
|
November 11, 2003
Pharmaceutical development of a parenteral lyophilized formulation of the investigational polymer-conjugated platinum anticancer agent AP 5280
M Bouma, B Nuijen, R Harms, et al.
Archives of Toxicology
|
February 18, 2024
Demonstrating the reliability of in vivo metabolomics based chemical grouping: towards best practice
Mark R Viant, E Amstalden, T Athersuch, et al.
Page
of 6